Cardiac Arrhythmias Diagnosis Prognosis Therapy
Asked to organize an international meeting on Propafenone (Ryt monorm) we had to question ourselves, whether to accept this offer just as interested physicians or in our capacity as chairmen of the study group on arrhythmias and intracardiac electrograph
- PDF / 13,631,815 Bytes
- 244 Pages / 482 x 692 pts Page_size
- 72 Downloads / 205 Views
Springer-Verlag Berlin Heidelberg New York 1983
Professor Dr. M. Schlepper Kerckhoff-Klinik of the Max-Planck-Society BenekestraBe 4-6 0-6350 Bad Nauheim Dr. B. Olsson Department of Cardiology Sahlgrenska University Hospital S-41345 Goteborg
ISBN·13: 978-3·642·68928-4 DOl: lD/lD07/978-3-642-68926-0
e-ISBN-13: 978-3-642-68926-0
Library of Congress Cataloging in Publication Data International Rytmononn-Congress (1st: ) Cardiac arrhythmias. 1. Arrhythmia--Congresses. 2. Arrhythmia--Chemotherapy--Congresses. 3. Propafenone-Testing--Congresses. I.Schlepper, M. (Martin), 1928. II.Olsson, B. (Bertil), 1941III. Title. [DNLM: 1. Arrhythmias. WG 330 C2649] RC685.A651561983 616.1'28 83-350
This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically those of translation, reprinting, re-use of illustrations. broadcasting, reproduction by photocopying machine or similar means, and storage in data banks. Under § 54 of the Gennan Copyright Law where copies are made for other than private use a fee is payable to "Verwertungsgesellschaft Wort", Munich. ©Springer·Verlag Berlin Heidelberg 1983 The use of general descriptive names, trade marks, etc. in this publication, even if the fonner are not especially identified, is not be taken as a sign that such names, as understood by the Trade Marks and Merchandise Marks Act, may accordingly by used freely by anyone. Type-setting and book binding: G.Appl, Wemding Printing: aprinta, Wemding 2121/3140-543210
Preface
Asked to organize an international meeting on Propafenone (Rytmonorm) we had to question ourselves, whether to accept this offer just as interested physicians or in our capacity as chairmen of the study group on arrhythmias and intracardiac electrography of the European Society of Cardiology. Considerung the "pros and contras" and well aware that one can easily be regarded as "product promoter" we, nevertheless, choose to organize the Symposion in association with the study group. We felt justified to do so for a number of reasons: Arrhythmias and their treatment as well as the tools to detect the first and to control the latter are well within the scope of the study group. An international symposion provided the opportunity to have the "state of the art" in arrhythmias and antiarrhythmic treatment thoroughly reviewed by internationally renowned investigators, thus serving an educational purpose. Furthermore it was the intention and aim of the meeting to have what is known about a fairly new drug presented in a critical manner and to point out what is not known, but should be known. It is in that context the presentations of the free session should be judged. To the careful reader it will become apparent that much which was not said, can be read "between the lines". To "set the stage" it is of utmost importance for the organizers not to be influenced in any way by the sponsors. It is gratefully acknowledged that Knoll AG was not only a generous sponsor as far as the scientific program is concerned but at
Data Loading...
